assess-target-drug-bd-opportunities-ls

【开发与工程】Integrate target biology, disease rationale, drug pipeline, clinical, patent, scientific, regulatory, company, and transaction evidence for target or targeted-asset R&D and business-development decisions. Use for target initiation reviews, asset or modality opportunity screens, partnering theses, target landscape updates, and evidence-based go/no-go …

独立 GitHub 快照 · 自动分类 · 以原作者文档为准